- Insight into J&J’s journey to implement real time multivariate analytics, PAT, modeling and feedback control
- Achieving integrated quality objectives, reducing non-conformance, enhancing quality control, and enabling real time release
- Integration of digitalization, data, and Quality By Design to intensify processes for flexible and modular manufacturing tailored to customer requirements in quality, price, quantity, and delivery
- Exploring the lessons learnt from the real-time release journey and their alignment with J&J’s long-term vision of quality-driven progress
Olav Lyngberg
VP Innovation and Technology Deployment, Janssen Supply Chain
The Janssen Pharmaceutical Companies of Johnson & Johnson
Olav Lyngberg, PhD leads the MSAT Innovation and Technology Deployment team within, J&J Innovative Medicine Supply Chain. Olav is responsible for orchestrating a talented and innovation-focused group of scientists and engineers to accelerate technology scouting and deployment in the internal and external network of mfg. sites, while leveraging new emerging innovation ideas across platforms, and products.
Prior to his current role Olav was Sr. Scientific Fellow, MSAT where he led teams responsible for developing and deploying technological solutions in manufacturing, to address issues in the areas of process robustness, process efficiency, release timelines and advanced process control.
Before joining J&J, Olav worked for Bristol-Myers Squibb Company as part of Chemical Development. At BMS Olav held roles spanning Process Engineer, Innovation and Technology lead and CMC leader. Olav holds a PhD in Chemical Engineering from University of Minnesota and a Master of Science in Biotechnology from the Technical University of Denmark.
